Comment on: Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database-Reference-Cited by-同舟云学术

Comment on: Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database

Published:2024-01 Issue: Volume:17 Page:
ISSN:1756-2864
Container-title:Therapeutic Advances in Neurological Disorders
language:en
Short-container-title:Ther Adv Neurol Disord

Author:

Khouri Charles¹²^ORCID,Hlavaty Alex³²^ORCID,Revol Bruno³²,Salvo Francesco⁴⁵,Raschi Emanuel⁶

Affiliation:

1. Pharmacovigilance Unit, Grenoble Alpes University Hospital, Université Grenoble Alpes, F-38000 Grenoble, France

2. HP2, Inserm U1300, Université Grenoble Alpes, Grenoble, France

3. Pharmacovigilance Unit, Grenoble Alpes University Hospital, Université Grenoble Alpes, Grenoble, France

4. INSERM, BPH, Team AHeaD, U1219, Université de Bordeaux, Bordeaux, France

5. Service de Pharmacologie Médicale, CHU de Bordeaux, INSERM, U1219, Bordeaux, France

6. Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy

Publisher

SAGE Publications

Link

https://journals.sagepub.com/doi/pdf/10.1177/17562864241276847

Reference9 articles.

1. Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database

2. Altmetric. Altmetric database in JSON format. Unpublished raw data, https://sage.altmetric.com/details/161543995 (2024)

3. Drug Repurposing Using FDA Adverse Event Reporting System (FAERS) Database

4. Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems

5. The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration